Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy

European Journal of Cancer Prevention

Volumn 22, Issue 6, 2013, Pages 577-584

  García Zepeda, Sihomara P ^a   García Villa, Enrique ^a   Díaz Chávez, José ^b   Hernández Pando, Rogelio ^c   Gariglio, Patricio ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c National Institute for Medica Sciences and Nutrition Salvador Zubiran   (Mexico)

Author keywords

cell death; cervical cancer; lysosomal permeability; mitochondrial membrane potential; resveratrol

Indexed keywords

LIPOCORTIN 5; RESVERATROL;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DEATH; CELL MEMBRANE PERMEABILITY; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ANTICARCINOGENIC AGENTS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NF-KAPPA B; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; STILBENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84885187265     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328360345f     Document Type: Article

References (33)

1. Alkhalaf M (2007). Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Eur J Cancer Prev 16:334-341.
2. Benitez DA, Hermoso MA, Pozo-Guisado E, Fernandez-Salguero PM, Castellon EA (2009). Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. Prostate 69:1045-1054.
3. Bishayee A (2009). Cancer prevention and treatment with resveratrol: From rodent studies to clinical trials. Cancer Prev Res (Phila) 2:409-418.
4. Brunelli D, Tavecchio M, Falcioni C, Frapolli R, Erba E, Iori R, et al. (2010). The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. Biochem Pharmacol 79:1141-1148.
5. Chalah A, Khosravi-Far R (2008). The mitochondrial death pathway. Adv Exp Med Biol 615:25-45.
6. Chow AW, Murillo G, Yu C, van Breemen RB, Boddie AW, Pezzuto JM, et al. (2005). Resveratrol inhibits rhabdomyosarcoma cell proliferation. Eur J Cancer Prev 14:351-356.
7. Espinosa M, Cantu D, Lopez CM, De la Garza JG, Maldonado VA, Melendez-Zajgla J (2004). SMAC is expressed de novo in a subset of cervical cancer tumors. BMC Cancer 4:84.
8. Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S (2005). Sensitivity to Fas-mediated apoptosis in high-risk HPVpositive human cervical cancer cells: Relationship with Fas, caspase-8, and Bid. Gynecol Oncol 97:353-364.
9. Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, et al. (2011). Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 4: 1419-1425.
10. Hsu KF,Wu CL, Huang SC,Wu CM, Hsiao JR, Yo YT, et al. (2009). Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy 5:451-460.
11. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
12. Juan ME, Majio M, Planas JM (2010). Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J Pharm Biomed Anal 51:391-398.
13. Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, et al. (2011). SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301:F427-F435.
14. Kramer MP, Wesierska-Gadek J (2009). Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose. Ann N Y Acad Sci 1171:257-263.
15. Kundu JK, Surh YJ (2008). Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 269:243-261.
16. Le Bras M, Rouy I, Brenner C (2006). The modulation of inter-organelle cross-talk to control apoptosis. Med Chem 2:1-12.
17. Leon-Galicia I, Diaz-Chavez J, Garcia-Villa E, Uribe-Figueroa L, Hidalgo-Miranda A, Herrera LA, et al. (2012). Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells. Eur J Cancer Prev 22: 11-20.
18. Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA, et al. (2002). Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 168:748-755.
19. Malhotra A, Nair P, Dhawan DK (2011). Curcumin and resveratrol synergistically stimulate p21 and regulate COX-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 20:411-416.
20. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP (2009). Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev 18:13-25.
21. Narisawa-Saito M, Kiyono T (2007). Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci 98:1505-1511.
22. Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, et al. (2009). Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 1:25-37.
23. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, et al. (2010). Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70:7392-7399.
24. Phongsavan K, Phengsavanh A, Wahlstrom R, Marions L (2010). Women's perception of cervical cancer and its prevention in rural Laos. Int J Gynecol Cancer 20:821-826.
25. Roccaro AM, Leleu X, Sacco A, Moreau AS, Hatjiharissi E, Jia X, et al. (2008). Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia. Clin Cancer Res 14:1849-1858.
26. Rosenbluth JM, Pietenpol JA (2009). mTOR regulates autophagy-associated genes downstream of p73. Autophagy 5:114-116.
27. Trincheri NF, Nicotra G, Follo C, Castino R, Isidoro C (2007). Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis 28:922-931.
28. Tsuchihara K, Fujii S, Esumi H (2009). Autophagy and cancer: Dynamism of the metabolism of tumor cells and tissues. Cancer Lett 278:130-138.
29. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, et al. (2004). Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23:1845-1853.
30. Zhang Y, Wu Y, Wu D, Tashiro S, Onodera S, Ikejima T (2009). NF-kappa b facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway. Arch Biochem Biophys 489:25-33.
31. Zhu W, Qin W, Zhang K, Rottinghaus GE, Chen YC, Kliethermes B, et al. (2012). Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr Cancer 64:393-400.
32. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, et al. (2002). Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 175:165-173.
33. Zur Hausen H (2000). Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.